Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Kalincik T, Brown JWL, Robertson N, Willis M, Scolding N, Rice CM, Wilkins A, Pearson O, Ziemssen T, Hutchinson M, McGuigan C, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Alroughani R, Pucci E, Sola P, Hupperts R, Lechner-Scott J, Terzi M, Van Pesch V, Rozsa C, Grand'Maison F, Boz C, Granella F, Slee M, Spitaleri D, Olascoaga J, Bergamaschi R, Verheul F, Vucic S, McCombe P, Hodgkinson S, Sanchez-Menoyo JL, Ampapa R, Simo M, Csepany T, Ramo C, Cristiano E, Barnett M, Butzkueven H, Coles A; MSBase Study Group. Kalincik T, et al. Among authors: scolding n. Lancet Neurol. 2017 Apr;16(4):271-281. doi: 10.1016/S1474-4422(17)30007-8. Epub 2017 Feb 11. Lancet Neurol. 2017. PMID: 28209331 Free article.
Cell therapy in demyelinating diseases.
Rice C, Halfpenny C, Scolding N. Rice C, et al. Among authors: scolding n. NeuroRx. 2004 Oct;1(4):415-23. doi: 10.1602/neurorx.1.4.415. NeuroRx. 2004. PMID: 15717045 Free PMC article. Review.
Strategies for achieving and monitoring myelin repair.
Rice C, Scolding N. Rice C, et al. Among authors: scolding n. J Neurol. 2007 Mar;254(3):275-83. doi: 10.1007/s00415-006-0455-x. Epub 2007 Mar 7. J Neurol. 2007. PMID: 17345032 Review.
Contribution of relapses to disability in multiple sclerosis.
Hirst C, Ingram G, Pearson O, Pickersgill T, Scolding N, Robertson N. Hirst C, et al. Among authors: scolding n. J Neurol. 2008 Feb;255(2):280-7. doi: 10.1007/s00415-008-0743-8. Epub 2008 Jan 23. J Neurol. 2008. PMID: 18204919
Stem cells in genetic myelin disorders.
Kemp K, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Among authors: scolding n. Regen Med. 2010 May;5(3):425-39. doi: 10.2217/rme.10.10. Regen Med. 2010. PMID: 20455653 Review.
239 results